| Next-generation sequencing: advances and applications in cancer diagnosis S Serratì, S De Summa, B Pilato, D Petriella, R Lacalamita, S Tommasi, ... OncoTargets and therapy, 7355-7365, 2016 | 201 | 2016 |
| Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue S Ciavarella, MC Vegliante, M Fabbri, S De Summa, F Melle, G Motta, ... Annals of Oncology 29 (12), 2363-2370, 2018 | 113 | 2018 |
| GATK hard filtering: tunable parameters to improve variant calling for next generation sequencing targeted gene panel data S De Summa, G Malerba, R Pinto, A Mori, V Mijatovic, S Tommasi BMC bioinformatics 18, 57-65, 2017 | 106 | 2017 |
| Neutrophils, crucial, or harmful immune cells involved in coronavirus infection: a bioinformatics study N Hemmat, A Derakhshani, H Bannazadeh Baghi, N Silvestris, ... Frontiers in genetics 11, 551872, 2020 | 101 | 2020 |
| Role of miR-27a, miR-181a and miR-20b in gastric cancer hypoxia-induced chemoresistance K Danza, N Silvestris, G Simone, M Signorile, L Saragoni, O Brunetti, ... Cancer biology & therapy 17 (4), 400-406, 2016 | 80 | 2016 |
| BRCAness: a deeper insight into basal-like breast tumors S De Summa, R Pinto, D Sambiasi, D Petriella, V Paradiso, A Paradiso, ... Annals of oncology 24, viii13-viii21, 2013 | 80 | 2013 |
| Gene expression comparison between the lymph node-positive and-negative reveals a peculiar immune microenvironment signature and a theranostic role for WNT targeting in … A Argentiero, S De Summa, R Di Fonte, RM Iacobazzi, L Porcelli, ... Cancers 11 (7), 942, 2019 | 79 | 2019 |
| Cancer-associated angiogenesis: the endothelial cell as a checkpoint for immunological patrolling AG Solimando, SD Summa, A Vacca, D Ribatti Cancers 12 (11), 3380, 2020 | 74 | 2020 |
| Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma S Serratì, M Guida, R Di Fonte, S De Summa, S Strippoli, RM Iacobazzi, ... Molecular Cancer 21 (1), 20, 2022 | 66 | 2022 |
| Unclassified variants in BRCA genes: guidelines for interpretation P Radice, S De Summa, L Caleca, S Tommasi Annals of oncology 22, i18-i23, 2011 | 64 | 2011 |
| MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis K Danza, S De Summa, R Pinto, B Pilato, O Palumbo, G Merla, G Simone, ... Oncotarget 6 (1), 471, 2015 | 55 | 2015 |
| Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression AG Solimando, MC Da Vià, P Leone, P Borrelli, GA Croci, P Tabares, ... haematologica 106 (7), 1943, 2021 | 53 | 2021 |
| Exhaled breath condensate biomarkers for lung cancer A Campanella, S De Summa, S Tommasi Journal of breath research 13 (4), 044002, 2019 | 52 | 2019 |
| HOX gene methylation status analysis in patients with hereditary breast cancer B Pilato, R Pinto, S De Summa, R Lambo, A Paradiso, S Tommasi Journal of human genetics 58 (1), 51-53, 2013 | 49 | 2013 |
| Nuclear PARP1 expression and its prognostic significance in breast cancer patients A Mazzotta, G Partipilo, S De Summa, F Giotta, G Simone, A Mangia Tumor Biology 37 (5), 6143-6153, 2016 | 40 | 2016 |
| KRAS-driven lung adenocarcinoma and B cell infiltration: novel insights for immunotherapy P Rosamaria, P Daniela, L Rosanna, M Michele, C Annamaria, P Pamela, ... Cancers 11 (8), 1145, 2019 | 35 | 2019 |
| Weighted gene co-expression network analysis combined with machine learning validation to identify key modules and hub genes associated with SARS-CoV-2 infection H Karami, A Derakhshani, M Ghasemigol, M Fereidouni, ... Journal of clinical medicine 10 (16), 3567, 2021 | 32 | 2021 |
| Rapid serological assays and SARS-CoV-2 real-time polymerase chain reaction assays for the detection of SARS-CoV-2: comparative study AV Paradiso, S De Summa, D Loconsole, V Procacci, A Sallustio, ... Journal of Medical Internet Research 22 (10), e19152, 2020 | 32 | 2020 |
| P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma C Costa, P Indovina, E Mattioli, IM Forte, CA Iannuzzi, L Luzzi, C Bellan, ... Cell Death & Disease 11 (9), 748, 2020 | 32 | 2020 |
| miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome D Petriella, S De Summa, R Lacalamita, D Galetta, A Catino, ... Tumor Biology 37, 5503-5513, 2016 | 30 | 2016 |
